| Filed On | Filing |
|---|---|
| 14 Apr 2025 |
8-K/A: Changes in Registrant's Certifying Accountant
(a) Dismissal of Independent Registered Public Accounting Firm. |
| 20 Nov 2020 |
8-K/A: Financial Statements and Exhibits
We consent to the incorporation by reference in the following Registration Statements: |
| 20 Feb 2020 |
8-K/A: Unregistered Sales of Equity Securities; Amendments to Articles/Bylaws; Change in Fiscal Year
On February 13, 2020, Novus Therapeutics, Inc. (the “Company”) entered into an exchange agreement (the “Exchange Agreement”) with Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P. and Biotechnology Value Trading Fund OS, ... |
| 25 Jul 2017 |
8-K/A: Financial Statements and Exhibits
On December 21, 2016, Tokai Pharmaceuticals, Inc. (“Tokai”), a Delaware corporation, Otic Pharma, and the shareholders of Otic Pharma (each a “Seller” and collectively, the “Sellers”), entered into a Share Purchase Agreement (the “Share ... |
Loading...